Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Pergola, Pablo E; Devalaraja, Matt; Fishbane, Steven; Chonchol, Michel; Mathur, Vandana S; Smith, Mark T; Lo, Larry; Herzog, Kurt; Kakkar, Rahul; Davidson, Michael H

Pergola, Pablo E; Devalaraja, Matt; Fishbane, Steven; Chonchol, Michel; Mathur, Vandana S; Smith, Mark T; Lo, Larry; Herzog, Kurt; Kakkar, Rahul; Davidson, Michael H.

Affiliation

Pergola PE; Renal Associates, P.A., San Antonio, Texas.
Devalaraja M; Corvidia Therapeutics, Inc., Waltham, Massachusetts.
Fishbane S; Division of Nephrology, Department of Medicine, Donald and Barbara Zucker School of Medicine, Great Neck, New York.
Chonchol M; Division of Renal Medicine Disease and Hypertension, University of Colorado, Aurora, Colorado.
Mathur VS; Mathur Consulting, Woodside, California.
Smith MT; Nephrology Associates, Augusta, Georgia.
Lo L; Corvidia Therapeutics, Inc., Waltham, Massachusetts.
Herzog K; Corvidia Therapeutics, Inc., Waltham, Massachusetts.
Kakkar R; Pandion Therapeutics, Inc., Waltham, Massachusetts.
Davidson MH; Corvidia Therapeutics, Inc., Waltham, Massachusetts.

J Am Soc Nephrol ; 32(1): 211-222, 2021 01.

Article in En | MEDLINE | ID: mdl-33272965

Subject(s)
Key words

anemia; cardiovascular disease; chronic kidney disease; erythropoietin stimulating agents; hemodialysis; inflammation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Renal Dialysis / Antibodies, Monoclonal, Humanized / Inflammation / Anemia / Kidney Failure, Chronic Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2021 Document type: Article Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google